36C10X27Q0014.docx

DOCX document 26 KB Posted

Attached to
6515--NX EQ Autotransfusion Units (VA-27-00010063)
Solicitation number
36C10X27Q0014
Issued by

About this file

This is a Combined Synopsis/Solicitation Notice and Request for Quote (RFQ) for Autotransfusion Units issued by the Department of Veterans Affairs Enterprise Procurement Office in Frederick, Maryland. The VA seeks to procure Haemonetics Call Saver Elite + brand name or equal autologous blood recovery systems for delivery to VA Medical Centers nationwide. The requirement encompasses 17 contract line items including the main processing unit (CSE-EX-US Cell Saver Elite Plus), disposable processing kits in various volumes (70mL, 125mL, 225mL), reservoir assemblies, RBC bags, waste bags, vacuum and aspiration lines, sequestration kits, annual recertification, service agreements, and training services. Quotes must address all CLINs listed in the Price Cost Schedule (Attachment A), with vendors permitted to propose equal products provided they meet nine defined salient characteristics covering functionality, processing capabilities, user interface, mobility, safety features, regulatory compliance, and support for intraoperative and postoperative procedures across cardiac, orthopedic, trauma, vascular, transplant, and OBGYN surgeries.

The solicitation is an unrestricted, full and open single award requirements contract with a 12-month base year and four 12-month option years under FAR Part 16.5, with firm-fixed-price orders and FOB destination delivery. Questions are due by 10:00 AM Eastern Time on November 16, 2026, and quotes must be submitted via email by 10:00 AM EST on November 23, 2026, to Contract Specialist Jalima Jones and Contracting Officer Sara Vickroy. All quoters must be registered in the System for Award Management (SAM) prior to submission. The NAICS code is 339112 (Surgical and Medical Instrument Manufacturing), Product Service Code 6515, with a size standard of 800 employees. The solicitation incorporates FAR provisions and clauses through FAC 2026-01 and includes attachments addressing price cost schedule, contract administration, clauses, provisions, reporting tools, and past performance requirements.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Combined Synopsis/Solicitation Notice Combined Synopsis/Solicitation Notice

SUBJECT*
NX EQ Autotransfusion Units (VA-27-00010063)

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
21703
SOLICITATION NUMBER*
36C10X27Q0014
RESPONSE DATE/TIME/ZONE
11-23-2026 10:00am EASTERN TIME, NEW YORK, USA
ARCHIVE
99 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N

SET-ASIDE

PRODUCT SERVICE CODE*
6515
NAICS CODE*
339112
CONTRACTING OFFICE ADDRESS
Enterprise Procurement Office

Department of Veterans Affairs

5202 Presidents Court, Suite 103 Frederick MD 21703

POINT OF CONTACT*

Contract Specialist Jalima J. Jones Jalima.Jones@va.gov

PLACE OF PERFORMANCE

ADDRESS
Nationwide

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

AGENCY’S URL
https://www.va.gov/opal/sac/index.asp
URL DESCRIPTION
VA | OALC | OPAL | SAC
AGENCY CONTACT’S EMAIL ADDRESS
Jalima.Jones@va.gov
EMAIL DESCRIPTION
Jalima.Jones@va.gov

DESCRIPTION

Solicitation Number:

36C10X27Q0014 Notice Type:

Combined Synopsis/Solicitation

This is a combined synopsis/solicitation for brand name, or equal commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation will not be issued.

Solicitation number 36C10X27Q0014 is issued for this combined synopsis/solicitation; this solicitation is being issued as a Request for Quote (RFQ). This combined synopsis/solicitation incorporates provisions and clauses in effect through Federal Acquisition Circular (FAC) 2026-01, dated 13 March 2026.

Requirement Description:

VA has a requirement to purchase Autotransfusion Units to deliver patient care to its VA Medical Centers around the country. An Autotransfusion Units also known as an autologous blood recovery system, is a system that provides hospitals with an easy-to-use, reliable way to recover a patient’s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular and OBGYN surgeries. Once recovered, the blood is washed and delivered to a product bag. The complete system is designed to be intuitive and flexible for optimal performance, supporting exceptional patient care.

A single award Requirements contract will be awarded as a Brand Name or Equal in accordance with all terms, conditions, provisions, specifications, and schedule of this solicitation herein. Quotes shall contain the terms for cost/price and technical capabilities of the brand name or equal equipment. The Government reserves the right to award without discussions.

The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 – Surgical and Medical Instrument Manufacturing, Product Service Code: 6515 Medical and Surgical Instruments, Equipment, and Supplies. The associated size standard is 800 employees. This procurement action is Unrestricted Full and Open.

This acquisition is for a single award Requirements contract in accordance with FAR Part 16.5 for Haemonetics™ Call Saver® Elite® + brand name or equal to Autotransfusion Units as identified in ATTACHMENT A – PRICE COST SCHEDULE - NX EQ AUTOTRANSFUSION UNITS. All interested companies shall provide a QUOTE for all Contract Line-Item Numbers (CLINs) listed in ATTACHMENT A – PRICE COST SCHEDULE - NX EQ AUTOTRANSFUSION UNITS.

The ordering period is for one 12-month base year with four 12-month option years. Delivery is a FOB destination. Firm-Fixed Price Orders will be placed against this contract in writing and will provide the delivery locations, delivery dates and exact quantities.

The FAR provision at 52.212-1, Instructions to Offerors – Commercial Products and Commercial Services, applies to this acquisition including attached addenda to the provision.

The FAR provision at 52.212-2, Evaluation -- Commercial Products and Commercial Services Items, and the specific evaluation criteria as attached addenda also applies to this acquisition.

Clause 52.212-4, Terms and Conditions -- Commercial Products and Commercial Services, applies to this acquisition and a statement regarding any addenda to the clause. Addendum is attached.

All interested quoters must be registered in the System for Award Management (SAM) prior to submitting a quote. You may access SAM at https://sam.gov/SAM/.

Questions regarding this combined synopsis/solicitation are due via email by 10:00 AM Eastern Standard Time (EST) on November 16, 2026, to Contract Specialist, Jalima Jones at Jalima.Jones@va.gov and Contracting Officer, Sara Vickroy at Sara.Vickroy@va.gov No calls will be accepted. Quotes are due via email by 10:00 AM EST on November 23, 2026, to Contract Specialist, Jalima Jones at Jalima.Jones@va.gov and Contracting Officer, Sara Vickroy at Sara.Vickroy@va.gov

1. SCOPE OF WORK

The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified Autotransfusion Units product line as a candidate for a VA-wide (otherwise referred to as “national”) single Requirements contract award.

Autotransfusion Units, also known as an autologous blood recovery system, is a system that provides hospitals with an easy-to-use, reliable way to recover a patient’s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular and OBGYN surgeries. Once recovered, the blood is washed and delivered to a product bag. The complete system is designed to be intuitive and flexible for optimal performance, supporting exceptional patient care.

The Contractor must demonstrate the ability to meet all requirements for the solicitation. The objective is to provide Autotransfusion Units to be used by VHA clinicians throughout the United States and its territories. The period of performance is for one 12-month base period with four 12-month option periods.

2. REQUIREMENT

This requirement will be, “Brand Name or Equal” which requires the quoter indicate that each product being offered as an “equal” product to Haemonetics™ Call Saver® Elite® + or equal Autotransfusion Units. For each equal product, the quoter must include a description reflecting the salient characteristics (SCs) and level of quality that will satisfy the salient physical, functional, or performance characteristics of the equal product(s) specified in the solicitation. The quoter must also clearly identify the item by brand name (if any) and make/model number. Finally, the offeror must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer (CO) and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements.

The following line-items comprise the Autotransfusion Units product line:

Contract Line-Item Number

Brand

Part Number

Description

0001
Haemonetics
00205-00
RESERVOIR, HARD-SHELL, 150u
0002
Haemonetics
00208-00
BASIC A & A ASSEMBLY, LN 208
0003
Haemonetics
00220-00
RESERVOIR, HARD-SHELL, 20U
0004
Haemonetics
00245-00
RBC BAG W/TWIST-LOCK CONNECTOR
0005
Haemonetics
CSE-B-1000
BAG ASSY, WASTE, 10L
0006
Haemonetics
CSE-FP-125V
CE ELITE FASTPACK,125mL,150u
0007
Haemonetics
CSE-FP-225V
CS ELITE FASTPACK,225ML,150U
0008
Haemonetics
CSE-P-125
CS ELITE PROCESSING KIT, 125ML
0009
Haemonetics
CSE-P-225
CS ELITE PROCESSING KIT, 225ML
0010
Haemonetics
CSE-P-70
CS ELITE PROCESSING KIT, 70ML
0011
Haemonetics
CSE-SQ-1000
SEQUESTRATION KIT, CSE-SQ-1000
0012
Haemonetics
HAR-A-1000
VACUUM LINE, FILTERED
0013
Haemonetics
HAR-A-0013
ASPIRATION & ANTICOAG LINE
0014
Haemonetics
CSE-EX-US
CELL SAVER ELITE PLUS, US
0015
Haemonetics
RECERTIFICATION
ANNUAL ONLINE RECERTIFICATION
0016
Haemonetics
Cell saver Service
1 Year Platinum Service Agreement
0017
Haemonetics
Training Tuition
Training

The Department of Veterans Affairs (VA) is seeking vendors who can provide Haemonetics™ Call Saver® Elite® + brand name or equal to Autotransfusion Units as listed above which meet all the following salient characteristics.

Vendors may quote any product solution or configuration so long as they meet the salient characteristics. Products quoted in the technical volume must be captured on the Vendor’s pricing volume (Attachment A, Price Cost Schedule) of the solicitation. Vendors may quote any additional ancillary products which they deem to be essential to the functionality of the proposed solution; these items must be captured in the Vendor’s pricing volume with a quantity of zero.

SC #
Salient Characteristics
Method of Evaluation
Applicable CLINs
Page # Where SC is Found in Technical Literature
SC1
Collects, separates, washes, and concentrates red blood cells to produce packed RBCs for reinfusion.
Literature Review
0014
SC2
Provides multiple automated processing modes (standard, low‑volume/pediatric, rapid/emergency) with defined throughput/output rates that support continuous or rapid access to washed RBCs during surgery.
Literature Review
0014
SC3
Produces high‑hematocrit washed RBCs with high RBC recovery achieving a strong removal of non‑RBC components (plasma proteins, free hemoglobin, anticoagulant, potassium, fat).
Literature Review
0014
SC4
Provides an intuitive touchscreen user interface with guided workflows and clear process / status indicators
Literature Review
0014
SC5
Compact, mobile system suitable for OR environments, with ergonomic features that support perfusionist / auto-transfusionist workflow.
Literature Review
0014
SC6
Includes alarms and safety interlocks for process parameters, vacuum, fluid levels, and product quality, with reliability appropriate for high‑use OR settings.
Literature Review
0014
SC7
Cleared/approved as an autotransfusion device under applicable regulations and standards
Literature Review
0014
SC #
Salient Characteristics
Method of Evaluation
Applicable CLINs
Page # Where SC is Found in Technical Literature
SC8
Uses single‑use disposable sets that are quick to install and prime, minimizing setup time and steps.
Literature Review
0001 - 0013
SC #
Salient Characteristics
Method of Evaluation
Applicable CLINs
Page # Where SC is Found in Technical Literature
SC9
Supports intraoperative and postoperative autologous blood collection, processing, and reinfusion for medium to high blood loss procedures (cardiac, orthopedic, trauma, vascular, transplant, OBGYN)..
Literature Review
0001 - 0014

The following attachments are incorporated by reference. All criteria outlined in the attachments are applicable to this combined synopsis/solicitation.

See attached document: ATTACHMENT A - PRICE COST SCHEDULE - NX EQ AUTOTRANSFUSION UNITS.

See attached document: ATTACHMENT B - CONTRACT ADMINISTRATION - NX EQ AUTOTRANSFUSION UNITS.

See attached document: ATTACHMENT C - CONTRACT CLAUSES - NX EQ AUTOTRANSFUSION UNITS.

See attached document: ATTACHMENT D - SOLICITATION PROVISIONS - NX EQ AUTOTRANSFUSION UNITS.

See attached document: ATTACHMENT E - REPORTING TOOL - NX EQ AUTOTRANSFUSION UNITS.

See attached document: ATTACHMENT F - PAST PERFORMANCE REFERENCE - NX EQ AUTOTRANSFUSION UNITS.

See attached document: ATTACHMENT G - PAST PERFORMANCE QUESTIONNAIRE - NX EQ AUTOTRANSFUSION UNITS.

*= Required Field
Combined Synopsis/Solicitation Notice

Combined Synopsis/Solicitation Notice

File details come from the government source that posted it. Updated .